Skip to content

Acute Exercise and Energy Balance Regulation: Effect of Intensity

Regulation of the Energy Balance Following an Acute Exercise in Metabolic Chambers: Effect of the Exercise Intensity, Age and Weight Status

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01036360
Enrollment
40
Registered
2009-12-21
Start date
2009-12-31
Completion date
2011-06-30
Last updated
2011-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Obesity, Acute exercise, Intensity of exercise, Energy balance regulation, Appetite

Brief summary

Physical activity is mainly considered and use for its impact on energy expenditure in the treatment of obesity, and less is known concerning its indirect effects on energy intake. The aim of this work is to clarify the impact of an acute bout of exercise, depending on its intensity (high versus low), on the following energy intake and nutrient utilization, in obese and non-obese boys and men.

Detailed description

20 adolescent boys (10 obese and 10 leans) and 20 men (10 obese and 10 lean) will complete a sub-maximal test on a ergo cycle to draw their linear relationship between VO2 and Fc. Then they will enter a metabolic chamber three times, for 24 hours each. A first session will be considered as sedentary, and volunteers will remain inactive. During the second and third session, they will have to complete a cycling test generating an energy expenditure of 400 Kcal, once at low intensity (40%VO2max) and once at high intensity (70% VO2max). Those three sessions will be realized in a randomized order with an interval of at least 7 days and urinary collection over the 24hours will be done during all the sessions. At the beginning of the protocol, blood samples will be taken, body composition assessed by DXA and adiposity location evaluated by MNR.

Interventions

20 adolescent boys (10 obese and 10 leans) and 20 men (10 obese and 10 lean) will complete a sub-maximal test on a ergo cycle to draw their linear relationship between VO2 and Fc. Then they will enter a metabolic chamber three times, for 24 hours each

Sponsors

Regional Program for Clinical Research 2009 (PHRC 2009)
CollaboratorUNKNOWN
Thermal Institution of Brides les Bains (FRANCE)
CollaboratorUNKNOWN
University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Male * Adults between 18 to 30 years old and adolescents between 12 and 15 years old * Body mass index : * lean adults : 20 \<BMI\< 25 kg.m² * obese adults : 30\<BMI\<38 kg.m² * lean adolescents: BMI \<90th percentile * obese adolescents: BMI\>97th percentile * Affiliated to National Health Insurance * Subject giving his written informed consent * Subject considered as normal after clinical examination and medical questionnaire.

Exclusion criteria

* Chronic pathologies : cardiovascular diseases, cancer, chronic inflammation diseases, renal, intestinal impairments * Refusal to be registered on the National Volunteers Data file * Being in exclusion on the National Volunteers Data file * Practising intensive physical exercise * Heavy consumer of alcohol or/and tobacco * Previous medical and/or surgery judged by the investigator as incompatible with this study

Design outcomes

Primary

MeasureTime frame
The amount of energy intake over the 24 hours is the primary outcome. It will be assessed during the 3 experimental conditions: sedentary, low intensive exercise, high intensive exerciseover the 24 hours

Secondary

MeasureTime frame
Appetite feeling and substrate utilization are the two second outcomes. It will be assessed during the 3 experimental conditions: sedentary, low intensive exercise, high intensive exercisewith an interval of at least 7 days

Countries

France

Contacts

Primary ContactPatrick LACARIN
placarin@chu-clermontferrand.fr04 73 75 11 95

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 27, 2026